Longwood Fund

  • About
  • Portfolio
  • Team
  • Press
  • Investor Login
  • Industry Events
  • About
  • Portfolio
  • Team
  • Press
  • Investor Login
  • Industry Events

Treating autism through the gut? Axial Therapeutics refuels on its exploration of the gut-brain axis

October 13, 2021

Axial Therapeutics Grabs $37.3 Million for Autism Clinical Trials With Teens

October 13, 2021

Axial Therapeutics tops up funding for phase 2 autism trial with $37M series C

October 13, 2021

Lassen Therapeutics Announces the Appointment of a Highly Experienced Biotech Executive to its Board of Directors and the Expansion of its Scientific and Clinical Advisory Board with Leading Experts in Pulmonary Fibrosis and Clinical Development

October 8, 2021

Pyxis Announces Pricing of Upsized Initial Public Offering

October 8, 2021

ImmuneID Appoints Veteran Biotech Executive James S. Scibetta as CEO

September 21, 2021
« Older Entries
Newer Entries »

Longwood Fund

The Prudential Tower

800 Boylston Street
Suite 1715
Boston, MA, 02199

  • About
  • Portfolio
  • Team
  • Press
  • Investor Login
  • Industry Events

© Longwood Fund. All Rights Reserved